High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center
Open Access
- 14 September 2017
- journal article
- Published by Elsevier BV in RBGO Gynecology & Obstetrics
- Vol. 39 (4), 325-330
- https://doi.org/10.1016/j.bjhh.2017.08.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Treatment of Hodgkin Lymphoma: A 50-Year PerspectiveJournal of Clinical Oncology, 2014
- Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysisThe Lancet Oncology, 2013
- Hodgkin's lymphoma mortality in the Americas, 1997–2008: Achievements and persistent inadequaciesInternational Journal of Cancer, 2013
- Dosimetric and Clinical Outcomes of Involved-Field Intensity-Modulated Radiotherapy After Chemotherapy for Early-Stage Hodgkin’s Lymphoma With Mediastinal InvolvementInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group seriesLeukemia & Lymphoma, 2012
- Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysisAnnals of Oncology, 2012
- Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Journal of Clinical Oncology, 2009
- Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Treatment of Advanced Hodgkin's Disease: EBVD versus Intensive Brief ChemotherapyLeukemia & Lymphoma, 2003
- Epstein‐Barr virus infection and human malignanciesInternational Journal of Experimental Pathology, 2001